Patient Guide: A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 123 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06211764
Status: 🟢 Enrolling Now
Condition: Non-Muscle Invasive Bladder Neoplasms
Phase: PHASE3

Where You Can Participate

This study is available at 123 locations across the country.

Top locations include:
  • • Little Rock, Arkansas
  • • Los Alamitos, California
  • • Los Angeles, California
  • • And 120 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) - Join Clinical Trial NCTNCT06211764

How to Join This Clinical Trial - NCTNCT06211764

Learn how to participate in this PHASE3 trial studying an investigational therapy for Non-Muscle Invasive Bladder Neoplasms. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-Muscle Invasive Bladder Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-Muscle Invasive Bladder Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06211764 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 123 locations. Find a study site near you:

Clinical Research Site

Little Rock, Arkansas 72211 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Los Alamitos, California 90720 - United States

Status: COMPLETED

Clinical Research Site

Los Angeles, California 90033 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Orange, California 92868 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

San Francisco, California 94158 2549 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Torrance, California 90503 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Lakewood, Colorado 80228 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Riverview, Florida 33578 - United States

Status: COMPLETED

Clinical Research Site

Chicago Ridge, Illinois 60415 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: ACTIVE_NOT_RECRUITING

And 113 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Non-Muscle Invasive Bladder Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships